OBJECTIVE: As data about prevalence and standard of care in short bowel syndrome (SBS) are not available for Germany, this study estimated the prevalence and assessed the medical infrastructure to potentially improve care of SBS patients. METHODS: In a validated approach for prevalence estimation in rare diseases, a randomized census of 478 size-stratified hospitals with surgical, internal medicine and pediatric departments was conducted to estimate SBS prevalence. The number of SBS patients, specialized outpatient clinics and caregiver expertise were assessed. RESULTS: The response rate was 85 % of randomized hospitals (405/478). Strata-derived estimation yielded a total of 2,808 SBS patients in Germany for 2011/2012 (95 % CI: 1750.3865), translating into a prevalence estimation for 34/million inhabitants (95 % CI: 21.47). Overall expertise in SBS treatment was only rated "satisfactory" by most caregivers. While 86 specialized outpatient clinics were identified, there was no central registry to access these resources. CONCLUSION: Short bowel syndrome, with a newly estimated prevalence of 34/million inhabitants is not a very rare medical condition in Germany. The interdisciplinary approach needed for optimal care for SBS patients would be greatly facilitated by a central registry.
OBJECTIVE: As data about prevalence and standard of care in short bowel syndrome (SBS) are not available for Germany, this study estimated the prevalence and assessed the medical infrastructure to potentially improve care of SBSpatients. METHODS: In a validated approach for prevalence estimation in rare diseases, a randomized census of 478 size-stratified hospitals with surgical, internal medicine and pediatric departments was conducted to estimate SBS prevalence. The number of SBSpatients, specialized outpatient clinics and caregiver expertise were assessed. RESULTS: The response rate was 85 % of randomized hospitals (405/478). Strata-derived estimation yielded a total of 2,808 SBSpatients in Germany for 2011/2012 (95 % CI: 1750.3865), translating into a prevalence estimation for 34/million inhabitants (95 % CI: 21.47). Overall expertise in SBS treatment was only rated "satisfactory" by most caregivers. While 86 specialized outpatient clinics were identified, there was no central registry to access these resources. CONCLUSION:Short bowel syndrome, with a newly estimated prevalence of 34/million inhabitants is not a very rare medical condition in Germany. The interdisciplinary approach needed for optimal care for SBSpatients would be greatly facilitated by a central registry.
Authors: A Pascher; J Klupp; R J Schulz; S Kohler; G Junge; I M Sauer; W Veltzke-Schlieker; A Adler; O Guckelberger; N C Nüssler; A Dignass; J M Langrehr; P Neuhaus Journal: Dtsch Med Wochenschr Date: 2005-02-25 Impact factor: 0.628
Authors: H Schäffler; A M Daraban; S Roggenbrod; U Schumacher; A Königsrainer; M Gregor; G Lamprecht Journal: Z Gastroenterol Date: 2011-03-09 Impact factor: 2.000
Authors: Y Lin; A Tamakoshi; S Matsuno; K Takeda; T Hayakawa; M Kitagawa; S Naruse; T Kawamura; K Wakai; R Aoki; M Kojima; Y Ohno Journal: J Gastroenterol Date: 2000 Impact factor: 7.527
Authors: K Miura; H Nakagawa; Y Morikawa; S Sasayama; A Matsumori; K Hasegawa; Y Ohno; A Tamakoshi; T Kawamura; Y Inaba Journal: Heart Date: 2002-02 Impact factor: 5.994
Authors: Geert I Koffeman; Wim G van Gemert; Elvira K George; Roeland A Veenendaal Journal: Best Pract Res Clin Gastroenterol Date: 2003-12 Impact factor: 3.043
Authors: Marc Schoeler; Thomas Klag; Judith Wendler; Simon Bernhard; Michael Adolph; Andreas Kirschniak; Martin Goetz; Nisar Malek; Jan Wehkamp Journal: Therap Adv Gastroenterol Date: 2018-08-30 Impact factor: 4.409